SCHEMBL5861896

SCHEMBL5861896

Cc1ccc(CCc2oc(-c3ccc(C(F)(F)F)cc3)cc2CO)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.42
MAOB P27338 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2E1 P05181 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2A6 P11509 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP4B1 P13584 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP3A5 P20815 1/20 0.38
CYP2A7 P20853 1/20 0.38
CYP3A7 P24462 1/20 0.38
CYP2F1 P24903 1/20 0.38
CYP2C18 P33260 1/20 0.38
CYP2C19 P33261 1/20 0.38
CYP2J2 P51589 1/20 0.38
CYP4F2 P78329 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5860604 0.86 S1PR1 (0.42) FFAR1MAOBCYP1A1CYP1A2CYP2E1
SCHEMBL3111585 0.81 CYP1A1 (0.43) FFAR1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL5861739 0.81 CYP1A1 (0.40) FFAR1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL3909054 0.81 EIF4A1 (0.40) FFAR1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL5861211 0.79 CYP1A1 (0.41) FFAR1MAOBCYP1A1CYP1A2CYP2E1
SCHEMBL1745043 0.78 CYP1A1 (0.44) FFAR1MAOBCYP1A1CYP1A2CYP2E1
SCHEMBL3107826 0.78 CYP1A1 (0.40) FFAR1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL6166408 0.77 PPARD (0.41) FFAR1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL5862035 0.76 PRMT1 (0.40) FFAR1CYP1A1CYP1A2CYP2E1CYP3A4
SCHEMBL3906472 0.76 CYP1A1 (0.39) FFAR1MAOBCYP1A1CYP1A2CYP2E1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7091237-B2 Furan and thiophene derivatives that activate human peroxisome proliferator activated receptors SMITHKLINE BEECHAM CORPORATION (US) 2006-08-15 US disclosed
EP-1392674-B1 FURAN AND THIOPHENE DERIVATIVES THAT ACTIVATE HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTORS SMITHKLINE BEECHAM CORP (US) 2005-08-10 EP disclosed
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors GLAXO GROUP LIMITED (GB) 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040157890-A1 Furan and thiophene derivatives that activate human peroxisome profilerator activated receptors PPARG, PPARD, PPARA FFAR1 4/4885MAOB 4039/4885CYP1A1 213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.